Insights

Employer Recognition CIPLA USA has been repeatedly recognized as a Great Place To Work, signaling strong employer branding and potential advantages in attracting skilled manufacturing, QA, and engineering talent for expansion or new production lines.

Growth Hiring Active recruitment across manufacturing, quality control, engineering, and operations suggests planned capacity expansion or process enhancements; opportunities exist to position contract manufacturing, equipment, or quality services to support scale-up.

Recall & Compliance Past recall issues at the key facility and patent-related litigation history indicate a potential need for robust quality assurance, remediation services, or secondary monitoring solutions to mitigate risk and strengthen supply reliability.

Launch Track Recent product launches and depot injections demonstrate a pipeline of injectable products and generic expansions; sales opportunities exist in formulation development, packaging, labeling, and compliance-ready API supply for U.S. market introductions.

Financial Scale With modest revenue in the tens of millions and a mid-sized employee base, CIPLA USA represents a growth-focused account where targeted value plays around cost-effective manufacturing, regulatory support, and digital analytics tooling could yield efficiency gains.

Similar companies to CIPLA USA

CIPLA USA Tech Stack

CIPLA USA uses 8 technology products and services including Google Analytics, Drupal, Google Font API, and more. Explore CIPLA USA's tech stack below.

  • Google Analytics
    Analytics
  • Content Management System
  • Google Font API
    Font Scripts
  • jQuery
    Javascript Libraries
  • OWL Carousel
    Javascript Libraries
  • Windows Server
    Operating Systems
  • Platform As A Service
  • Google Tag Manager
    Tag Management

Media & News

CIPLA USA's Email Address Formats

CIPLA USA uses at least 6 email formats:
CIPLA USA Email FormatsExamplePercentage
First.Last@cipla.comJohn.Doe@cipla.com
84%
F.Last@cipla.comJ.Doe@cipla.com
10%
First@cipla.comJohn@cipla.com
4%
FirstLast@cipla.comJohnDoe@cipla.com
2%
First.Last@ciplausa.comJohn.Doe@ciplausa.com
67%
FLast@ciplausa.comJDoe@ciplausa.com
33%

Frequently Asked Questions

What is CIPLA USA's official website and social media links?

Minus sign iconPlus sign icon
CIPLA USA's official website is ciplausa.com and has social profiles on LinkedIn.

How much revenue does CIPLA USA generate?

Minus sign iconPlus sign icon
As of July 2026, CIPLA USA's annual revenue is estimated to be $10M - $25M.

What is CIPLA USA's NAICS code?

Minus sign iconPlus sign icon
CIPLA USA's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does CIPLA USA have currently?

Minus sign iconPlus sign icon
As of July 2026, CIPLA USA has approximately 81 employees across 2 continents, including North America and Asia. Key team members include Manufacturing Manager: M. P., Principal: E. M. and Senior Chargeback Analyst: S. B. Explore CIPLA USA's employee directory with LeadIQ.

What industry does CIPLA USA belong to?

Minus sign iconPlus sign icon
CIPLA USA operates in the Pharmaceuticals industry.

What technology does CIPLA USA use?

Minus sign iconPlus sign icon
CIPLA USA's tech stack includes Google Analytics, Drupal, Google Font API, jQuery, OWL Carousel, Windows Server, Microsoft Azure and Google Tag Manager.

What is CIPLA USA's email format?

Minus sign iconPlus sign icon
CIPLA USA's email format typically follows the pattern of First.Last@cipla.com. Find more CIPLA USA email formats with LeadIQ.
CIPLA USA logo

CIPLA USA

PharmaceuticalsFlorida, United States51-200 Employees

CIPLA USA is a pharmaceutical manufacturing company based in Miami, Florida, focused on producing medicines for the U.S. market. The business maintains operations across manufacturing, quality control, engineering, and general operations, reflecting its production-centric role in the sector. It is a mid-sized producer in the pharmaceutical manufacturing sector, with facilities and functions that cover core production disciplines.

The company's product history includes the launch of Leuprolide Acetate Injection Depot 22.5 mg in 2022 and Daptomycin for Injection in 2019, illustrating its involvement in injectable therapies for the U.S. market. It has faced quality and regulatory events, such as a 2021 recall of six batches of Albuterol Sulfate inhalation Aerosol (90 mcg), disclosed in later reporting. More recently, CIPLA USA has been recognized as a Great Place To Work in 2023 and again in 2025, and it is actively recruiting for roles across manufacturing, quality control, engineering, and operations.

Section iconCompany Overview

NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Employees
51-200

Section iconFunding & Financials

  • $10M - $25M

    CIPLA USA's revenue is estimated to be in the range of $10M - $25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.